Open-Label Safety Study of AXS-05 in Subjects With Depression
NCT04039022
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
876
Enrollment
INDUSTRY
Sponsor class
Conditions
Major Depressive Disorder
Treatment Resistant Depression
Depression
Interventions
DRUG:
AXS-05 (dextromethorphan and bupropion) oral tablets
Sponsor
Axsome Therapeutics, Inc.